{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-195471","form_type":"8-K","ticker":null,"cik":"0001808158","company_name":"Repare Therapeutics Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.596957+00:00","generated_at":"2026-05-31T11:51:32.024016+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Briggs Morrison resigns from Repare board; Steven Stein to chair Science & Tech Committee","bullets":["Dr. Briggs Morrison resigned as Class III director and chair of Science and Technology Committee, effective Aug 6, 2024.","Steven H. Stein, M.D. appointed as new chair of the Science and Technology Committee, effective Aug 6, 2024.","Resignation not due to any disagreement with Repare's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-195471","json":"https://secwatch.observer/filing/0001193125-24-195471.json","markdown":"https://secwatch.observer/filing/0001193125-24-195471.md","text":"https://secwatch.observer/filing/0001193125-24-195471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524195471/0001193125-24-195471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524195471/d881881d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:51:32.024016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39b9758c09","claim":"Steven H. Stein, M.D. was appointed as Chair of the Science and Technology Committee at Repare Therapeutics Inc..","evidence_excerpt":"Steven H. Stein, M.D. replaced Dr. Morrison as chair of the Science and Technology Committee, effective as of August 6, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524195471/0001193125-24-195471-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chair of the Science and Technology Committee"}],"fact_type":"executive_change"},{"claim_id":"79bb38371f","claim":"Briggs Morrison, M.D. resigned as Class III Director at Repare Therapeutics Inc..","evidence_excerpt":"On August 1, 2024, Briggs Morrison, M.D. notified the board of directors (the “Board”) of Repare Therapeutics Inc. (the “Company”) of his decision to resign as a Class III director and as chair of the Science and Technology Committee of the Board, effective as of August 6, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808158/000119312524195471/0001193125-24-195471-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}